Dan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dan Liu has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Nasir Ahmad Aziz
Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
10 shared publications - Monique M. B. Breteler
Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
9 shared publications Ruiqi Wang
Department of Biostatistics, Boston University School of Public Health, Boston, MA, 02118, USA
4 shared publicationsJuliana F. Tavares
Population Health Sciences, German Centre for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany
3 shared publications- Mohammed Aslam Imtiaz
Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
3 shared publications Qiong Yang
Department of Biostatistics, Boston University School of Public Health, Boston, MA, 02118, USA; The Framingham Heart Study, Framingham, MA, 01701, USA
3 shared publications
Latest Publications
- Open Access
Unraveling the genetic architecture of the human mammillary bodies
The mammillary bodies are a central component of the hippocampal–diencephalic-cingulate network that is critically involved in emotion processing and memory function, yet their genetic architecture remains unknown. We conducted a genome-wide association study (GWAS) of mammillary body volume in 38,064 participants from the UK Biobank and replicated our findings in the Rhineland Study cohort (N = 4,860). Mammillary body and hypothalamic subregional volumes were derived from structural brain MRIs using FastSurfer-HypVINN, an established and validated deep learning-based segmentation tool. Univariate GWAS identified 34 genomic loci associated with mammillary body volume, including 26 novel loci, with 20 loci showing replication in the Rhineland Study. Meta-analysis across both cohorts (N = 42,924) identified 44 associated loci, of which 35 were novel. Multivariate GWAS of hypothalamic subregions identified 55 loci, including 40 novel associations. Integrative cross-omics analyses identified MEI1 and CAPZA1 as key molecular candidates, with genetically regulated MEI1 expression and circulating CAPZA1 protein levels partially mediating genetic effects on mammillary body volume. Genetic correlation and Mendelian randomization analyses further revealed a bidirectional relationship between mammillary body volume and major depressive disorder. Together, our findings elucidate the genetic architecture of mammillary body volume and its relation to mental disorders.
Open AccessUnraveling the genetic architecture of the human mammillary bodies
The mammillary bodies are a central component of the hippocampal–diencephalic-cingulate network that is critically involved in emotion processing and memory function, yet their genetic architecture remains unknown. We conducted a genome-wide association study (GWAS) of mammillary body volume in 38,064 participants from the UK Biobank and replicated our findings in the Rhineland Study cohort (N = 4,860). Mammillary body and hypothalamic subregional volumes were derived from structural brain MRIs using FastSurfer-HypVINN, an established and validated deep learning-based segmentation tool. Univariate GWAS identified 34 genomic loci associated with mammillary body volume, including 26 novel loci, with 20 loci showing replication in the Rhineland Study. Meta-analysis across both cohorts (N = 42,924) identified 44 associated loci, of which 35 were novel. Multivariate GWAS of hypothalamic subregions identified 55 loci, including 40 novel associations. Integrative cross-omics analyses identified MEI1 and CAPZA1 as key molecular candidates, with genetically regulated MEI1 expression and circulating CAPZA1 protein levels partially mediating genetic effects on mammillary body volume. Genetic correlation and Mendelian randomization analyses further revealed a bidirectional relationship between mammillary body volume and major depressive disorder. Together, our findings elucidate the genetic architecture of mammillary body volume and its relation to mental disorders.
- Open Access
- 29 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9232
Associations between diet quality, epigenetic aging and epigenome in two population-based cohorts
Several dietary patterns have been associated with better health outcomes. However, the extent to which adherence to different so-called healthy diets overlaps, whether these dietary patterns are equally beneficial, and whether they are associated with similar DNA methylation profiles, remains unclear. Therefore, we investigate the overlap in adherence to ten diet quality scores, and examine the associations of these scores with both biological aging markers and DNA methylation profiles. We use data from the Rhineland Study, a large population-based cohort, and validated our findings using corresponding data from the EPIC-Potsdam cohort. Here, we show minimal overlap of participants classified in the highest quartile (top 25%) of adherence across different diet quality scores. Adherence to a healthy dietary pattern is associated with reduced epigenetic aging, although associations differed in magnitude across diet quality scores. Different dietary patterns are associated with distinct methylation profiles, which however largely converged onto the same biological pathways. Our findings suggest that general adherence to a healthy dietary pattern could promote health through similar epigenetic mechanisms, despite variations in dietary composition.
- 29 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9232
Open AccessAssociations between diet quality, epigenetic aging and epigenome in two population-based cohorts
Several dietary patterns have been associated with better health outcomes. However, the extent to which adherence to different so-called healthy diets overlaps, whether these dietary patterns are equally beneficial, and whether they are associated with similar DNA methylation profiles, remains unclear. Therefore, we investigate the overlap in adherence to ten diet quality scores, and examine the associations of these scores with both biological aging markers and DNA methylation profiles. We use data from the Rhineland Study, a large population-based cohort, and validated our findings using corresponding data from the EPIC-Potsdam cohort. Here, we show minimal overlap of participants classified in the highest quartile (top 25%) of adherence across different diet quality scores. Adherence to a healthy dietary pattern is associated with reduced epigenetic aging, although associations differed in magnitude across diet quality scores. Different dietary patterns are associated with distinct methylation profiles, which however largely converged onto the same biological pathways. Our findings suggest that general adherence to a healthy dietary pattern could promote health through similar epigenetic mechanisms, despite variations in dietary composition.
- Open Access
- 11 May 2026
- Published by Elsevier in EBioMedicine
- Vol. 128, 106289
DNA methylation signatures of bilateral hippocampal volume, asymmetry and atrophy: a cross-omics analysis in the general population
- 11 May 2026
- Published by Elsevier in EBioMedicine
- Vol. 128, 106289
Open AccessDNA methylation signatures of bilateral hippocampal volume, asymmetry and atrophy: a cross-omics analysis in the general population
- Top Cited PapersOpen Access
- 17 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy
Mitochondrial damage constitutes the central pathological mechanism of cerebral ischemia-reperfusion (I/R) injury. Targeted delivery of antioxidants to mitochondria and the phenotype polarization of glial cells holds great promise for effective treatment. However, the blood-brain barrier (BBB) remains a major obstacle, causing insufficient drug accumulation in neuronal mitochondria. Here, we develop a bioengineered nanolamellar system (MM@BPPF) by coating microglia-mitochondria hybrid biomembrane onto black phosphorus nanosheets (BP NSs) loaded with polymetformin (PolyMet) and fingolimod hydrochloride (FTY720). Microglia membrane facilitates inflammation-directed targeting to the injured brain regions, while mitochondria membrane confers homotypic targeting to mitochondria. Meanwhile, BP NSs, PolyMet, and FTY720 act sequentially to restore mitochondrial function of neuronal cells and modulate microglial polarization. Intranasal administration enables MM@BPPF to bypass the BBB, substantially improving brain-targeting efficiency. This work not only offers an innovative sequential targeting strategy for mitigating I/R injury but also presents a potential paradigm for treating other central nervous system disorders.
- 17 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Top Cited PapersOpen AccessIntranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy
Mitochondrial damage constitutes the central pathological mechanism of cerebral ischemia-reperfusion (I/R) injury. Targeted delivery of antioxidants to mitochondria and the phenotype polarization of glial cells holds great promise for effective treatment. However, the blood-brain barrier (BBB) remains a major obstacle, causing insufficient drug accumulation in neuronal mitochondria. Here, we develop a bioengineered nanolamellar system (MM@BPPF) by coating microglia-mitochondria hybrid biomembrane onto black phosphorus nanosheets (BP NSs) loaded with polymetformin (PolyMet) and fingolimod hydrochloride (FTY720). Microglia membrane facilitates inflammation-directed targeting to the injured brain regions, while mitochondria membrane confers homotypic targeting to mitochondria. Meanwhile, BP NSs, PolyMet, and FTY720 act sequentially to restore mitochondrial function of neuronal cells and modulate microglial polarization. Intranasal administration enables MM@BPPF to bypass the BBB, substantially improving brain-targeting efficiency. This work not only offers an innovative sequential targeting strategy for mitigating I/R injury but also presents a potential paradigm for treating other central nervous system disorders.
- Open Access
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e099862
Integrative cross‐omics analysis identifies DNA methylation signatures associated with bilateral hippocampal volume, asymmetry and atrophy rate in the general population
Background: The hippocampus, a critical brain structure for learning and memory, exhibits left‐right volumetric differences (LHCV and RHCV) and asymmetry. However, the molecular underpinnings of these features remain largely unknown in the general population. Method: We performed a meta‐analysis of epigenome‐wide association studies (EWAS) across six population‐based cohorts (8,156 individuals, 53% women, mean age: 60.7 years, age range: 30 to 92 years) to identify blood‐based methylation signatures associated with LHCV, RHCV, and hippocampal asymmetry. Integrative cross‐omics analyses using individual‐level genetic, methylation, and gene expression data from Rhineland Study participants ( n > 2,624) was employed to elucidate the underlying molecular mechanisms. We further evaluated the relationships between ten dietary patterns, baseline methylation signatures, and longitudinal changes in hippocampal volumes and asymmetry. Result: Distinct CpG sites and differentially methylated regions (DMRs) for LHCV, RHCV, and hippocampal asymmetry converged on pathways related to neuronal differentiation and development. Integrative analyses identified 15 CpG/DMR‐gene expression pairs associated with LHCV and 18 pairs with RHCV, implicating immnue‐related (i.e. LGALS3BP and TREM5) and synaptic function genes (i.e. MIR181A1HG and CORO1B ). Baseline methylation at these loci was significantly associated with rates of bilateral hippocampal loss over time, explaning over 10% of the variation in hippocampal atrophy rates. Four CpGs were consistently associated with hippocampal asymmetry cross‐sectionally and longitudinally, with sex‐specific differences. Moreover, higher adherence to healthy dietary patterns was associated with these methylation signatures. Conclusion: Our findings reveal methylation signatures as potential biomarkers or therapeutic targets for age‐ or neurodegeneration‐related hippocampal atrophy. They further underscore the influence of modifiable dietary patterns on methylation and hippocampal health.
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e099862
Open AccessIntegrative cross‐omics analysis identifies DNA methylation signatures associated with bilateral hippocampal volume, asymmetry and atrophy rate in the general population
Background: The hippocampus, a critical brain structure for learning and memory, exhibits left‐right volumetric differences (LHCV and RHCV) and asymmetry. However, the molecular underpinnings of these features remain largely unknown in the general population. Method: We performed a meta‐analysis of epigenome‐wide association studies (EWAS) across six population‐based cohorts (8,156 individuals, 53% women, mean age: 60.7 years, age range: 30 to 92 years) to identify blood‐based methylation signatures associated with LHCV, RHCV, and hippocampal asymmetry. Integrative cross‐omics analyses using individual‐level genetic, methylation, and gene expression data from Rhineland Study participants ( n > 2,624) was employed to elucidate the underlying molecular mechanisms. We further evaluated the relationships between ten dietary patterns, baseline methylation signatures, and longitudinal changes in hippocampal volumes and asymmetry. Result: Distinct CpG sites and differentially methylated regions (DMRs) for LHCV, RHCV, and hippocampal asymmetry converged on pathways related to neuronal differentiation and development. Integrative analyses identified 15 CpG/DMR‐gene expression pairs associated with LHCV and 18 pairs with RHCV, implicating immnue‐related (i.e. LGALS3BP and TREM5) and synaptic function genes (i.e. MIR181A1HG and CORO1B ). Baseline methylation at these loci was significantly associated with rates of bilateral hippocampal loss over time, explaning over 10% of the variation in hippocampal atrophy rates. Four CpGs were consistently associated with hippocampal asymmetry cross‐sectionally and longitudinally, with sex‐specific differences. Moreover, higher adherence to healthy dietary patterns was associated with these methylation signatures. Conclusion: Our findings reveal methylation signatures as potential biomarkers or therapeutic targets for age‐ or neurodegeneration‐related hippocampal atrophy. They further underscore the influence of modifiable dietary patterns on methylation and hippocampal health.
- 15 July 2025
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 180, 107550
Mediating role of depression in the relationship between allostatic load and mortality
- 15 July 2025
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 180, 107550
Mediating role of depression in the relationship between allostatic load and mortality
- Open Access
- 4 May 2025
- Published by Wiley in Aging Cell
- Vol. 24 (8) , e70092
Age and Sex Effects on Blood Retrotransposable Element Expression Levels: Findings From the Population‐Based Rhineland Study
Retrotransposable elements (RTEs) have been implicated in the pathogenesis of several age‐associated diseases. Although model systems indicate that age‐ and sex‐dependent loss of heterochromatin increases RTE expression, data from large human studies are lacking. Here we assessed the expression levels of 795 blood RTE subfamilies in 2467 participants of the population‐based Rhineland Study. We found that the expression of more than 98% of RTE subfamilies increased with both chronological and biological age. Moreover, the expression of heterochromatin regulators involved in RTE silencing was negatively related to the expression of 690 RTE subfamilies. Finally, we observed sex differences in 42 RTE subfamilies, with higher expression in men. The genes mapped to sex‐related RTEs were enriched in immune response‐related pathways. Importantly, we validated our key findings in an independent population‐based cohort. Our findings indicate that RTEs and their repressors are markers of aging and that their dysregulation is linked to inflammation, especially in men.
- 4 May 2025
- Published by Wiley in Aging Cell
- Vol. 24 (8) , e70092
Open AccessAge and Sex Effects on Blood Retrotransposable Element Expression Levels: Findings From the Population‐Based Rhineland Study
Retrotransposable elements (RTEs) have been implicated in the pathogenesis of several age‐associated diseases. Although model systems indicate that age‐ and sex‐dependent loss of heterochromatin increases RTE expression, data from large human studies are lacking. Here we assessed the expression levels of 795 blood RTE subfamilies in 2467 participants of the population‐based Rhineland Study. We found that the expression of more than 98% of RTE subfamilies increased with both chronological and biological age. Moreover, the expression of heterochromatin regulators involved in RTE silencing was negatively related to the expression of 690 RTE subfamilies. Finally, we observed sex differences in 42 RTE subfamilies, with higher expression in men. The genes mapped to sex‐related RTEs were enriched in immune response‐related pathways. Importantly, we validated our key findings in an independent population‐based cohort. Our findings indicate that RTEs and their repressors are markers of aging and that their dysregulation is linked to inflammation, especially in men.
- Open Access
Integrative cross-omics analysis identifies DNA methylation signatures associated with bilateral hippocampal volume, asymmetry and atrophy rate in the general population
The hippocampus exhibits volumetric differences between the left and right hemispheres (LHCV and RHCV) and asymmetry, yet the molecular mechanisms underlying these features remain unclear. In this study, we performed a meta-analysis of epigenome-wide association studies (EWAS) across six population-based cohorts (n=8,156; 53% women; mean age: 60.7 years) to identify blood-based methylation signatures associated with LHCV, RHCV, and hippocampal asymmetry. Integrative cross-omics analyses using individual-level genetic, methylation, and gene expression data (n > 2,624 participants from the Rhineland Study) revealed 15 CpG/DMR-gene expression pairs linked to LHCV and 18 pairs to RHCV, implicating pathways involved in neuronal differentiation and immune processes. Notably, baseline methylation at these loci predicted bilateral hippocampal atrophy rates, explaining over 10% of the variation. Four CpGs were consistently associated with hippocampal asymmetry cross-sectionally and longitudinally, exhibiting sex-specific differences. Additionally, adherence to healthy dietary patterns was associated with these methylation signatures, highlighting modifiable influences on hippocampal health and atrophy.
Open AccessIntegrative cross-omics analysis identifies DNA methylation signatures associated with bilateral hippocampal volume, asymmetry and atrophy rate in the general population
The hippocampus exhibits volumetric differences between the left and right hemispheres (LHCV and RHCV) and asymmetry, yet the molecular mechanisms underlying these features remain unclear. In this study, we performed a meta-analysis of epigenome-wide association studies (EWAS) across six population-based cohorts (n=8,156; 53% women; mean age: 60.7 years) to identify blood-based methylation signatures associated with LHCV, RHCV, and hippocampal asymmetry. Integrative cross-omics analyses using individual-level genetic, methylation, and gene expression data (n > 2,624 participants from the Rhineland Study) revealed 15 CpG/DMR-gene expression pairs linked to LHCV and 18 pairs to RHCV, implicating pathways involved in neuronal differentiation and immune processes. Notably, baseline methylation at these loci predicted bilateral hippocampal atrophy rates, explaining over 10% of the variation. Four CpGs were consistently associated with hippocampal asymmetry cross-sectionally and longitudinally, exhibiting sex-specific differences. Additionally, adherence to healthy dietary patterns was associated with these methylation signatures, highlighting modifiable influences on hippocampal health and atrophy.
- Open Access
Age and sex effects on blood retrotransposable element expression levels: Findings from the population-based Rhineland Study
Retrotransposable elements (RTEs) have been implicated in the pathogenesis of several age-associated diseases. Although model systems indicate that age- and sex-dependent loss of heterochromatin increases RTE expression, data from large human studies are lacking. Here we assessed the expression levels of 795 blood RTE subfamilies in 2467 participants of the population-based Rhineland Study. We found that the expression of more than 98% of RTE subfamilies increased with both chronological and biological age. Moreover, the expression of heterochromatin regulators involved in RTE silencing were negatively related to the expression of 690 RTE subfamilies. Finally, we observed sex differences in 42 RTE subfamilies, with higher expression in men. The genes mapped to sex-related RTEs were enriched in immune response-related pathways. Importantly, we validated our key findings in an independent population-based cohort. Our findings indicate that RTEs and their repressors are markers of aging, and that their dysregulation is linked to inflammation, especially in men. Graphical
Open AccessAge and sex effects on blood retrotransposable element expression levels: Findings from the population-based Rhineland Study
Retrotransposable elements (RTEs) have been implicated in the pathogenesis of several age-associated diseases. Although model systems indicate that age- and sex-dependent loss of heterochromatin increases RTE expression, data from large human studies are lacking. Here we assessed the expression levels of 795 blood RTE subfamilies in 2467 participants of the population-based Rhineland Study. We found that the expression of more than 98% of RTE subfamilies increased with both chronological and biological age. Moreover, the expression of heterochromatin regulators involved in RTE silencing were negatively related to the expression of 690 RTE subfamilies. Finally, we observed sex differences in 42 RTE subfamilies, with higher expression in men. The genes mapped to sex-related RTEs were enriched in immune response-related pathways. Importantly, we validated our key findings in an independent population-based cohort. Our findings indicate that RTEs and their repressors are markers of aging, and that their dysregulation is linked to inflammation, especially in men. Graphical
- Open Access
- 19 July 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-8
Associations of methylmalonic acid and depressive symptoms with mortality: a population-based study
Methylmalonic acid (MMA), a biomarker of mitochondrial dysfunction, has been reported to be associated with depression in specific populations (i.e., older adults and postpartum women). Our study aimed to investigate to what extent MMA was associated with depressive symptoms and mortality in the general population, and assess whether depressive symptoms mediate the relationship between MMA and mortality. We analyzed cross-sectional data from 8343 participants from the US National Health and Nutrition Examination Survey. MMA was measured by liquid chromatography-tandem mass spectrometry, while depressive symptoms were measured by the Patient Health Questionnaire-9. Mortality data were obtained through linkage with National Death Index records. Linear regression models were performed to assess the association between MMA and depressive symptoms. The Cox proportional hazard regression model was utilized to assess the association of MMA and depressive symptoms with mortality. Mediation analysis was conducted within the counterfactual framework. In this general population, each SD (around 0.49 μmol/L) increase in MMA was associated with a 0.03 SD (approximately 0.15 score) increase in depressive symptoms (β = 0.033, 95% CI: 0.010, 0.055, p = 0.005). Notably, this association was more pronounced in men and participants over 60 years old. Higher levels of MMA and having more depressive symptoms were associated with a higher risk of mortality. However, depressive symptoms do not mediate the relationship between MMA and mortality. Elevated MMA levels were associated with depressive symptoms and an increased risk of mortality. These findings suggest that mitochondrial dysfunction may contribute to the multifactorial etiology of depression.
- 19 July 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-8
Open AccessAssociations of methylmalonic acid and depressive symptoms with mortality: a population-based study
Methylmalonic acid (MMA), a biomarker of mitochondrial dysfunction, has been reported to be associated with depression in specific populations (i.e., older adults and postpartum women). Our study aimed to investigate to what extent MMA was associated with depressive symptoms and mortality in the general population, and assess whether depressive symptoms mediate the relationship between MMA and mortality. We analyzed cross-sectional data from 8343 participants from the US National Health and Nutrition Examination Survey. MMA was measured by liquid chromatography-tandem mass spectrometry, while depressive symptoms were measured by the Patient Health Questionnaire-9. Mortality data were obtained through linkage with National Death Index records. Linear regression models were performed to assess the association between MMA and depressive symptoms. The Cox proportional hazard regression model was utilized to assess the association of MMA and depressive symptoms with mortality. Mediation analysis was conducted within the counterfactual framework. In this general population, each SD (around 0.49 μmol/L) increase in MMA was associated with a 0.03 SD (approximately 0.15 score) increase in depressive symptoms (β = 0.033, 95% CI: 0.010, 0.055, p = 0.005). Notably, this association was more pronounced in men and participants over 60 years old. Higher levels of MMA and having more depressive symptoms were associated with a higher risk of mortality. However, depressive symptoms do not mediate the relationship between MMA and mortality. Elevated MMA levels were associated with depressive symptoms and an increased risk of mortality. These findings suggest that mitochondrial dysfunction may contribute to the multifactorial etiology of depression.